This inventor holds 3 USPTO granted patents. Top assignees: Heidelberg Pharma Ag, Roche Diagnostics Gmbh, Other. Active years: 1999-2007.
Company Filing History:
1 out of 2 
1 out of 487 
1 out of 834,453 Years Active: 1999-2007
Title: The Innovations of Hans-George Opitz
Introduction
Hans-George Opitz is a notable inventor based in Weinheim, Germany. He has made significant contributions to the field of biochemistry, particularly in the development of novel enzymes and their applications in medicine. With a total of three patents to his name, Opitz has demonstrated a commitment to advancing scientific knowledge and practical applications.
Latest Patents
One of his latest patents involves a lipid cleavage enzyme that is extracted from cellular membrane fractions of blood leukocytes or monocytes/macrophages. This membranous enzyme, not yet described in the state-of-the-art, has potential applications in preparing medicaments that utilize its substrates as pharmaceutical active substances. These medicaments are designed to direct pharmacologically active substances to target cells, enriching them with these substances. Additionally, Opitz has disclosed in-vitro research systems that utilize this enzyme to detect other substrates.
Career Highlights
Throughout his career, Hans-George Opitz has worked with prominent companies, including Roche Diagnostics GmbH. His work has focused on the intersection of biochemistry and medicine, leading to innovative solutions that address complex health challenges.
Collaborations
Opitz has collaborated with notable colleagues such as Harald Zilch and Dieter Herrmann, contributing to a rich exchange of ideas and expertise in his field.
Conclusion
Hans-George Opitz's contributions to the field of biochemistry through his patents and collaborations highlight his role as an influential inventor. His work continues to pave the way for advancements in medical science and therapeutic applications.